Skip to content

Impact of Hypnosis During Invasive Procedure in Intensive Care Unit

Impact of Hypnosis During Invasive Procedure in Intensive Care Unit

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04399850
Acronym
HYPNOICU
Enrollment
124
Registered
2020-05-22
Start date
2020-09-28
Completion date
2024-03-28
Last updated
2024-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

invasive procedure, pain distress, hypnosis

Brief summary

Pain during ICU stay remains one of the major complaints for patients. Beside pain intensity, well described by patients' self reports, pain distress, which is an emotional experience, cannot be treated with usual analgesia. The aim of the study is to analyze the impact of hypnosis on pain intensity and distress on short and long term outcomes in non-sedated ICU patients.

Interventions

Patients who receive hypnosis

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients aged 18 years and older * ICU hospitalisation * Non-sedated patients who need an invasive procedure (Invasive procedures are defined as chest tube (insert or remove), fibroscopy, catheter insert, lumbar punction and bone marrow aspiration) * Physician experienced in hypnosis available * written informed consent * health insurance

Exclusion criteria

* sedation and intubation, delirium, end-of-life decision, * deaf patient, * patient who does not understand French language, * pregnancy * patient under guardianship or curatorship * lack of health insurance

Design outcomes

Primary

MeasureTime frameDescription
Pain distresswithin the before and the first hour after the procedurePain distress change in the hypnosis group measured before and within the first hour after the procedure. Pain distress will be assessed using Numeric rating scale, which goes from 0 (no pain stress) to 10 (maximum pain stress).

Secondary

MeasureTime frameDescription
Number of adverse eventsduring procedure
Length of each painful procedureup to 3 months
Analgesia dosewithin first and 24 hours after procedureThe dose of each analgesia treatment received by the patient will be collected.
Type of analgesiawithin first and 24 hours after procedureThe type of each analgesia treatment received by the patient will be collected.
Pain intensitywithin first hour and first 24 hours after procedurePain intensity will be assessed using Numeric rating scale, which goes from 0 (no pain) to 10 (maximum pain imaginable).
Hospital Anxiety and Depression (HAD) scaleat 3 monthsThe HAD scale is a self-assessment scale for detecting states of depression and anxiety in the setting of an hospital medical outpatient clinic. HAD scale is a self-administered scale of 14 items which assessed levels of depression and anxiety, divided into 2 subscales of 7 items (Anxiety or HADS-A, Depression or HADS-D). Each item is scored on a scale of 0 to 3. A score is generated for each of the two sub-scales (sum of the 7 items, ranging from 0 to 21). A higher score indicates worse outcome.
Post traumatic stress disorder assessed using Impact of Event Scale Revisited (IES R)at 3 monthsThe IES-R is a 22-item self-report measure (for DSM-IV) that assesses subjective distress caused by traumatic events. Items are rated on a 5-point scale ranging from 0 to 4 . The IES-R yields a total score (ranging from 0 to 88)
Proportion of patients who had hypnosis transeduring procedure
Description of the experience of hypnosisat 3 monthsQualitative analysis of the experience of hypnosis will be performed using the semi-structured interview
Anxietywithin first and 24 hours after procedureAnxiety within first and 24 hours after procedure will be assessed using Numeric rating scale, which goes from 0 (no anxiety) to 10 (maximum anxiety imaginable).

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026